Atlas Trials

A Phase 2 Study Adding Ascorbate to Chemotherapy and Radiation Therapy for NSCLC

Clinical trial NCT02905591 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT02905591
Sponsor
Joseph J. Cullen, MD, FACS
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Carcinoma, Non-Small-Cell LungNon-Small Cell Lung CancerNonsmall Cell Lung CancerNon-Small-Cell Lung CarcinomaNSCLC
Start date
2018-11-16
Primary completion
2025-07-15
Enrollment
43

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.